Home > Quotes > MJN

Mead Johnson Nutrition Company Stock Quote & Summary Data

MJN 
$95.08
*  
0.34
0.36%
Get MJN Alerts
*Delayed - data as of Jul. 23, 2014  -  Find a broker to begin trading MJN now
Exchange: NYSE
Industry: Consumer Non-Durables
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
1 Year Target: 96
Today's High/Low:  / 
Share Volume:
90 Day Avg. Daily Volume This is the average share volume for the past 50 trading days, for NASDAQ stocks and 90 trading days for Non-NASDAQ stocks. This field allows you to compare today's trading to the average daily volume. 1,320,740
Previous Close: $ 95.42
52 Week High /Low: $ 94.52 / $ 70.54
Market cap "Market Capitalization" is a measure of the estimated value of the common equity securities of the company or their equivalent. It does not include securities convertible into the common equity securities. �Market Capitalization� is derived from the last sale price for the displayed class of listed securities and the total number of shares outstanding for both listed and unlisted securities (as applicable). NASDAQ does not use this value to determine compliance with the listing requirements. $ 19,215,732,084
P/E Ratio: 28.47
Forward P/E(1y) A widely used stock evaluation measure. For a security, the Price/Earnings Ratio is given by dividing the Last Sale Price by the Average EPS (Earnings Per Share) Estimate for the specified fiscal time period. The forward P/E refers to the value for the next full year. 25.01
Earnings Per Share (EPS) The EPS listed on our infoquote and Summary Quote page is "12-mos Rolling". EPS represents the portion of a company's profit allocated to each outstanding share of common stock. Net income (reported or estimated) for a period of time is divided by the total number of shares outstanding (TSO) during that period; See growth rate measures for EPS. Our vendor's methodology for the EPS on the infoquote and Summary Quote pages follows the EPS used by the majority of the analysts following the stock, in many cases this is EBITDA EPS. $ 3.34
Annualized dividend $ 1.50
Ex Dividend Date Jun. 19, 2014
Dividend Payment Date Jul. 3, 2014
Current Yield 1.63 %
Beta 1.03

Intraday Chart

ETFs with MJN as a Top 10 Holding*

Weighting ETF Name (Symbol) 100-Day Price Change (%)
2.63% Guggenheim Mid-Cap Core ETF (CZA) +2.78  (6.04%)
2.62% Guggenheim S&P 500 Equal Weight Consumer Staples ETF (RHS) +6.17  (6.81%)
*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change.
**Green highlights the top performing ETF by % change in the past 100 days.

Company Description (as filed with the SEC)

In this Annual Report on Form 10-K, we refer to Mead Johnson Nutrition Company and its subsidiaries as “the Company,” “MJN,” “Mead Johnson,” “we” or “us.” Our Company Mead Johnson Nutrition Company is a global leader in pediatric nutrition with $4.2 billion in net sales for the year ended December 31, 2013. We are committed to being the world’s leading nutrition company for infants and children and to helping nourish the world’s children for the best start in life. Our Enfa family of brands, including Enfamil infant formula, is the world’s leading brand franchise in pediatric nutrition, based on retail sales. Our comprehensive product portfolio addresses a broad range of nutritional needs for infants, children and expectant and nursing mothers. We have over 100 years of innovation experience during which we have developed or improved many breakthrough or industry-defining products across each of our product categories.  ... More ...  

Consensus Recommendation

Research Brokers before you trade

Want to trade FX?